C9orf72-SMCR8-WDR41 complex (C9orf72-SMCR8)

The C9orf72-SMCR8 pathway is a critical regulatory axis in cellular proteostasis, primarily mediated by a protein complex comprising C9orf72, SMCR8, and WDR41 (UniProt Q96LT7, Q8TEH3). This complex functions as a Guanine Nucleotide Exchange Factor (GEF) for Rab GTPases, such as Rab8 and Rab39, thereby controlling vesicle trafficking and autophagy initiation (Sellier et al., 2016, PubMed: 27333014). It is most notably associated with the C9orf72 hexanucleotide repeat expansion, which is the leading genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (Renton et al., 2011, PubMed: 21944778). Pathogenesis involves a dual mechanism: the loss of normal C9orf72-SMCR8 complex function and the gain of toxicity from dipeptide repeat proteins (DPRs) and RNA foci (DeJesus-Hernandez et al., 2011, PubMed: 21944779). Therapeutic interventions focus on antisense oligonucleotides (ASOs) to silence the mutant transcript or small molecules designed to stabilize the complex and restore its GEF activity (ClinicalTrials.gov: NCT03626012). Additionally, the pathway is essential for immune homeostasis, as deficiency in the complex can lead to hyper-inflammation and autoimmune phenotypes in myeloid cells (O'Rourke et al., 2016, PubMed: 26989199). Monitoring therapeutic efficacy often involves measuring DPR levels, such as poly-GP, in the cerebrospinal fluid of patients (Gendron et al., 2017, PubMed: 28358215). Understanding the structural biology of the C9orf72-SMCR8 complex has become a focal point for developing precision medicines that address the underlying protein-handling defects in neurodegenerative diseases.

Other names

C9orf72-SMCR8 complexC9-SMCR8-WDR41 complexDENN-like protein complexC9orf72-SMCR8-WDR41 GEF complex

Modulation of the C9orf72-SMCR8 complex activity to restore autophagy or reduction of toxic repeat-associated products via antisense technology.